Chimeric antigen receptor T-cell therapy for T-ALL and AML

Chimeric antigen receptor T-cell therapy for T-ALL and AML

Non-B-cell acute leukemia is a term that encompasses T-cell acute lymphoblastic leukemia (T-ALL) and acute myeloid leukemia (AML). Currently, the therapeutic effectiveness of existing treatments for refractory or relapsed (R/R) non-B-cell acute leukemia is limited. In such situations, chimeric antig...

Full description

Bibliographic Details
Main Authors: Wenwen Wei, Dong Yang, Xi Chen, Dandan Liang, Liqun Zou, Xudong Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
chimeric antigen receptor
T-ALL
AML
antigen
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.967754/full

Similar Items

Similar Items